ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This study will evaluate the safety and efficacy of ALKS33 (RDC-0313) compared with placebo in adults with alcohol dependence. There will be 11 study visits conducted over a period of about 4 months. The study period includes a screening visit, a 12-week treatment period, and a follow-up visit.
Epistemonikos ID: 13a10a358c3125da45eb20f09464e0d9ea0754bc
First added on: May 05, 2024